Sam L. Barker, Director at Cyclacel Pharmaceuticals, Inc. (CYCC), bought 3,100 shares at $3.00 ($9K) on 2014-11-20, disclosed to the SEC on 2014-11-20.
Open-market purchase of $9k CYCC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| LXRX | BUY | 2019-08-02 | $28K | — | Filing → |
| LXRX | BUY | 2017-09-18 | $13K | — | Filing → |
| CADX | BUY | 2011-05-11 | $63K | — | Filing → |